Company Details
| Sector | PHARMACEUTICALS |
| Address | 35 - Dockyard Road West Wharf Karachi |
| Auditor | Yousuf Adil, Chartered Accountants |
| Registrar | CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi |
| Website | www.pk.gsk.com |
| Fiscal Year | December |
| Details |
Details
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V.@ incorporated in Netherlands@ whereas its ultimate parent company is GlaxoSmithKline plc@ UK (GSK plc).
Company Announcements
| Date/Time | Announcement |
|---|---|
| 23/08/2022 15:02:08 | EPS = 1.98 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 631.212 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,202.372 FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2022 |
| 07/06/2022 10:26:13 | PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,386.462 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 925.041 EPS = 2.90 FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2022 |
| 28/02/2022 11:32:13 | DIVIDEND = 70%(F) BOOK CLOSURE TO 25/04/2022 BOOK CLOSURE FROM 19/04/2022 ANNUAL GENERAL MEETING HELD ON 25/04/2022 EPS = 16.81 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 5,354.409 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 7,424.450 FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2021 |
| 25/10/2021 15:03:48 | FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2021 EPS = 9.11 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 2,901.015 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 4,354.214 |
| 23/08/2021 15:31:50 | PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,703.044 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,585.769 FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2021 EPS = 5.35 |